PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 5:04 AM ET

Sponsor Check › Person

CM
No photo found yet (own website and image search run after this page is viewed)

Christopher Mirabelli

Named as an officer, director or promoter on SEC Form D filings · MA, NJ, PA · Aug 1, 2011 → Nov 29, 2017

11deals (issuers)
$345.8Mreported sold
197investors
31Form D filings
2011–2017years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 3:02 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Christopher Mirabelli is listed as an executive officer and director on 31 SEC Form D filings by 11 issuers between May 2009 and Mar 2023. Largest by amount reported sold: Aro Biotherapeutics Co (Philadelphia, PA — pharmaceuticals — 2021–2022; $90.3M reported sold to 14 investors), LEAP THERAPEUTICS, INC. (Cambridge, MA — pharmaceuticals — 2011–2023; $77.2M reported sold to 121 investors), KINETA, INC./DE (Seattle, WA — biotechnology — 2011–2015; $70.6M reported sold to 17 investors), TREVENA INC (King of Prussia, PA — pharmaceuticals — 2010–2013; $60M reported sold to 9 investors), AnchorTherapeutics, Inc (Cambridge, MA — industry reported as "Other" — 2009–2010; $19M reported sold to 4 investors) and 6 more (all listed below).

What this means That is a lot of deals — 11 separate companies raised money with this person listed as executive officer and director, over about 14 years. Across those companies the filings report $345.8M sold in total.

Listed alongside Augustine Lawlor (7 shared filings), Russ Hawkinson (7 shared filings), Steven Gillis (7 shared filings), Wende Hutton (7 shared filings), Douglas E. Onsi (6 shared filings) and 81 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Christopher. Each name links to their own page.

The issuers belong to 2 sponsor groups: Healthcare (6 issuers, $81.2M reported sold, 2010–2023) and Kineta (8 issuers, $19M reported sold, 2010–2023).

What this means This person is listed across more than one sponsor team; each group page shows that team's full track record.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 2 court cases matching the name, 3 bankruptcy cases matching the name listed in Key records below.

What this means 5 records came back, including 1 court case still open — open cases can take years and cost money. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 31 public filings for Christopher Mirabelli and found 11 differences, 1 worth asking the sponsor about: 4 Form Ds were filed more than 15 days after the first sale; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Christopher Mirabelli has not run yet — it is joining a line of 5,882 names; searches run around the clock at the hosts' allowed rate. Searched so far: 27 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

2 cases: 1 open, 1 judgment

Mirabelli v. Fifth Third Bank, NA open
District Court, N.D. Illinois · No. 1:25-cv-14485 · Filed Nov 26, 2025 · Nature of suit: 890 Other Statutory Actions · Cause: 28:1331 Federal Question
Role of Mirabelli: Plaintiff · Outcome: Open — no termination date on the docket (bulk snapshot 2026-09-30) Docket on CourtListener ↗
same rare surname (4 people in Form D filings, 10 federal dockets); surname only in the caption; court in IL (not a filing state)
Trinity Mtge Co v. Mirabelli judgment
District Court, N.D. Illinois · No. 1:94-cv-02912 · Filed May 11, 1994 · Closed Jul 8, 1994 · Nature of suit: 220 Foreclosure
Role of Mirabelli: Defendant · Outcome: Terminated 1994-07-08 — FJC Integrated Database disposition: Judgment on default; judgment for plaintiff Docket on CourtListener ↗
same rare surname (4 people in Form D filings, 10 federal dockets); surname only in the caption; court in IL (not a filing state)
What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 3:02 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: AZ, CA, DE, TX, WA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Christopher Mirabelli..

State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states are not covered.

3. Bankruptcies

3 cases: 3 closed (disposition not in docket feed)

Christopher M. Mirabelli and Dana M. Mirabelli closed
United States Bankruptcy Court, D. New Jersey · No. 13-14122 · Filed Feb 28, 2013 · Closed Aug 25, 2016
Role of Christopher M. Mirabelli and Dana M. Mirabelli: Debtor · Outcome: Case closed 2016-08-25 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same rare surname (4 people in Form D filings, 10 federal dockets); first name matches; court in the person's filing state (NJ)
Joseph Mirabelli and Mary Ann Mirabelli closed
United States Bankruptcy Court, N.D. Illinois · No. 01-45156 · Filed Dec 21, 2001 · Closed Apr 11, 2002
Role of Joseph Mirabelli and Mary Ann Mirabelli: Debtor · Outcome: Case closed 2002-04-11 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same rare surname (4 people in Form D filings, 10 federal dockets); different first name (joseph); court in IL (not a filing state)
Mary Ann Mirabelli closed
United States Bankruptcy Court, N.D. Illinois · No. 87-01472 · Filed Jan 30, 1987 · Closed Jul 15, 1988
Role of Mary Ann Mirabelli: Debtor · Outcome: Case closed 1988-07-15 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same rare surname (4 people in Form D filings, 10 federal dockets); different first name (ann); court in IL (not a filing state)
What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 3:02 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

11 differences found between the filings for Christopher Mirabelli — 1 worth asking about (compared 31 filings on Oct 24, 2026)

Worth asking · Dec 13, 2006 – Mar 13, 2023

4 Form Ds were filed more than 15 days after the first sale

Form D filed 140 days after the first sale — Theraclone Sciences, Inc. · Form D filed 474 days after the first sale — Anexon, Inc. · Form D filed 1,406 days after the first sale — Anexon, Inc. · Form D filed 55 days after the first sale — LEAP THERAPEUTICS, INC.

What this means Late notices are common and carry no penalty by themselves. A pattern of late paperwork is worth asking the sponsor about.

Form D · Jul 29, 2013 ↗Theraclone Sciences, Inc. — PartnerFacts page ↗Form D · Oct 19, 2010 ↗Anexon, Inc. — PartnerFacts page ↗
Sources
Note · Nov 29, 2017 – Mar 13, 2023

Christopher Mirabelli's role changed at LEAP THERAPEUTICS, INC.: executive officer, director → director

The Nov 29, 2017 filing lists Christopher Mirabelli as executive officer, director; the Mar 13, 2023 Form D lists director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Form D · Nov 29, 2017 ↗Form D · Mar 13, 2023 ↗Christopher Mirabelli — PartnerFacts page ↗LEAP THERAPEUTICS, INC. — PartnerFacts page ↗
Sources
Note · Oct 7, 2014 – Sep 15, 2015

Offering amount changed between filings — KINETA, INC./DE

The Oct 7, 2014 filing says $10,000,000 offered; the Sep 15, 2015 Form D/A says $15,000,000.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Form D/A (earlier) · Oct 7, 2014 ↗Form D/A (later) · Sep 15, 2015 ↗KINETA, INC./DE — PartnerFacts page ↗
Sources
Note · Sep 12, 2011 – Nov 23, 2011

Offering amount changed between filings — Theraclone Sciences, Inc.

The Sep 12, 2011 filing says $10,584,603 offered; the Nov 23, 2011 Form D/A says $11,584,603.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Form D (earlier) · Sep 12, 2011 ↗Form D/A (later) · Nov 23, 2011 ↗Theraclone Sciences, Inc. — PartnerFacts page ↗
Sources
Note · Aug 15, 2008 – Dec 28, 2022

13 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — Aro Biotherapeutics Co (latest filing Dec 28, 2022) · No amendment in the last 12 months on an offering that may still be open — KINETA, INC./DE (latest filing Sep 15, 2015) · No amendment in the last 12 months on an offering that may still be open — Theraclone Sciences, Inc. (latest filing May 7, 2015) · No amendment in the last 12 months on an offering that may still be open — Theraclone Sciences, Inc. (latest filing Jul 29, 2013) · No amendment in the last 12 months on an offering that may still be open — TREVENA INC (latest filing May 17, 2013) · and 8 more

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D · Dec 28, 2022 ↗Aro Biotherapeutics Co — PartnerFacts page ↗Form D · Sep 15, 2015 ↗KINETA, INC./DE — PartnerFacts page ↗
Sources
Note · May 27, 2009 – Mar 17, 2010

Christopher Mirabelli is written 2 different ways on the filings

listed as "Christopher K. Mirabelli" on 10 filings (from May 27, 2009), and "Christopher Mirabelli" on 21 filings (from Mar 17, 2010).

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Form D/A · May 27, 2009 ↗Form D · Mar 17, 2010 ↗Christopher Mirabelli — PartnerFacts page ↗
Sources
Note · Jan 7, 2011 – Mar 13, 2023

Industry group changed between filings — LEAP THERAPEUTICS, INC.

"Pharmaceuticals" (Jan 7, 2011); then "Biotechnology" (Nov 29, 2017); then "Pharmaceuticals" (Mar 13, 2023).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D · Jan 7, 2011 ↗Form D · Nov 29, 2017 ↗Form D · Mar 13, 2023 ↗LEAP THERAPEUTICS, INC. — PartnerFacts page ↗
Sources
Note · Jun 2, 2011 – Aug 14, 2014

Industry group changed between filings — KINETA, INC./DE

"Other Health Care" (Jun 2, 2011); then "Biotechnology" (Aug 14, 2014 to Sep 15, 2015).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D/A · Jun 2, 2011 ↗Form D · Aug 14, 2014 ↗KINETA, INC./DE — PartnerFacts page ↗
Sources
Note · May 27, 2009 – Aug 23, 2010

Industry group changed between filings — AnchorTherapeutics, Inc

"Biotechnology" (May 27, 2009); then "Other" (Aug 23, 2010).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D/A · May 27, 2009 ↗Form D · Aug 23, 2010 ↗AnchorTherapeutics, Inc — PartnerFacts page ↗
Sources
Note · Jul 16, 2010 – May 17, 2013

Address moved from King of Prussia, PA to Waltham, MA — TREVENA INC

The people listed on the Jul 16, 2010 filing give King of Prussia, PA; on the May 17, 2013 filing they give Waltham, MA.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · Jul 16, 2010 ↗Form D · May 17, 2013 ↗TREVENA INC — PartnerFacts page ↗
Sources
Note · May 27, 2009 – Mar 13, 2023

Christopher Mirabelli is listed with 3 different address states: MA, NJ, PA

MA on 21 filings (May 27, 2009 to Mar 13, 2023); NJ on 4 filings (Mar 17, 2010 to Nov 23, 2011); PA on 6 filings (Nov 20, 2013 to Dec 28, 2022).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Form D/A · May 27, 2009 ↗Form D · Mar 17, 2010 ↗Form D · Nov 20, 2013 ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

2 of 24 offerings report sales commissions totalling $1,120,000; 0 report finder's fees; 1 reports proceeds to related persons totalling $720,000. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Mar 13, 2023 D
LEAP THERAPEUTICS, INC.
File 021-475708
$0$0$0None listed on this filingEDGAR ↗
Dec 28, 2022 D
Aro Biotherapeutics Co
File 021-468913
$0$0$0None listed on this filingEDGAR ↗
Dec 16, 2021 D/A
Aro Biotherapeutics Co
File 021-385223
$0$0$0None listed on this filingEDGAR ↗
Nov 29, 2017 D
LEAP THERAPEUTICS, INC.
File 021-299736
$400,000$0$0NONE no CRD number reported
via Raymond James & Associates, Inc. (CRD 705 ↗)

NONE no CRD number reported
via Ladenburg Thalmann & Co. Inc. (CRD 505 ↗)
EDGAR ↗
Sep 15, 2015 D/A
KINETA, INC./DE
File 021-222928
$0$0$0 (est.)None listed on this filingEDGAR ↗
Sep 15, 2015 D
KINETA, INC./DE
File 021-247685
$720,000 (est.)$0$720,000 (est.)
$720,000 in sales commission has been paid to Leerink Partners LLC (Irena Melnikova) in connection with the amount sold. Additional fees may be paid to Leerink Partners LLC in connection with the amount remaining to be sold.
Leerink Partners LLC BrokerCheck CRD 39011 ↗
via Irena Melnikova (CRD 6308893 ↗)
EDGAR ↗
May 7, 2015 D
Theraclone Sciences, Inc.
File 021-239360
$0$0$0None listed on this filingEDGAR ↗
Nov 20, 2013 D
GALLEON PHARMACEUTICALS INC
File 021-206691
$0$0$0 (est.)None listed on this filingEDGAR ↗
Jul 29, 2013 D/A
Theraclone Sciences, Inc.
File 021-200360
$0$0$0None listed on this filingEDGAR ↗
May 17, 2013 D
TREVENA INC
File 021-196667
$0$0$0None listed on this filingEDGAR ↗
Mar 26, 2013 D
Theraclone Sciences, Inc.
File 021-193896
$0$0$0None listed on this filingEDGAR ↗
Oct 10, 2012 D
SYNOVEX CORP
File 021-185289
$0$0$0None listed on this filingEDGAR ↗
Nov 23, 2011 D/A
Theraclone Sciences, Inc.
File 021-165656
$0$0$0None listed on this filingEDGAR ↗
Aug 1, 2011 D
Apofore Corp
File 021-163739
$0$0$0None listed on this filingEDGAR ↗
Jun 2, 2011 D/A
KINETA, INC./DE
File 021-122527
$0$0$0 (est.)None listed on this filingEDGAR ↗
Jan 7, 2011 D
LEAP THERAPEUTICS, INC.
File 021-153226
$0$0$0None listed on this filingEDGAR ↗
Oct 19, 2010 D
Anexon, Inc.
File 021-149305
$0$0$0None listed on this filingEDGAR ↗
Oct 19, 2010 D
Anexon, Inc.
File 021-149306
$0$0$0None listed on this filingEDGAR ↗
Oct 19, 2010 D
Anexon, Inc.
File 021-149307
$0$0$0None listed on this filingEDGAR ↗
Aug 23, 2010 D
AnchorTherapeutics, Inc
File 021-146793
$0$0$0 (est.)None listed on this filingEDGAR ↗
Jul 16, 2010 D
TREVENA INC
File 021-145133
$0$0$0None listed on this filingEDGAR ↗
Apr 27, 2010 D
HealthCare Ventures IX, L.P.
File 021-141176
$0$0$0 (est.)
The Issuer will pay HCV Management IX LLC, its Management Company, an annual management fee equal to a percentage of its committed capital or capital under management.
None listed on this filingEDGAR ↗
Mar 17, 2010 D
Theraclone Sciences, Inc.
File 021-71676
$0$0$0None listed on this filingEDGAR ↗
May 27, 2009 D/A
AnchorTherapeutics, Inc
File 021-110449
$0$0$0None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 11

Every issuer that named Christopher Mirabelli on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

LT
Pharmaceuticals · group: Healthcare

LEAP THERAPEUTICS, INC.

Cambridge, MA · Jan 7, 2011 → Mar 13, 2023 · 3 filings
  • Mar 13, 2023 · D · $77,219,193 sold of $77,219,193 · 121 investors · min. No minimum reported · role: Director (Dr. Mirabelli is the Chairman of the Board of Directors of the Issuer.) EDGAR ↗
  • Nov 29, 2017 · D · $18,000,001 sold of $18,000,001 · 14 investors · min. No minimum reported · role: Executive Officer, Director (Chief Executive Officer, President and Director) EDGAR ↗
  • Jan 7, 2011 · D · $9,930,400 sold of $30,500,000 · 4 investors · min. $2,930,400 · role: Executive Officer, Director EDGAR ↗

Raised $77.2M from 121 investors (100% of the $77.2M target) as of the latest filing. Christopher is listed as director, executive officer on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

AB
Pharmaceuticals

Aro Biotherapeutics Co

Philadelphia, PA · Jan 5, 2021 → Dec 28, 2022 · 5 filings
  • Dec 28, 2022 · D · $24,032,627 sold of $100,000,000 · 12 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 16, 2021 · D/A · $90,337,478 sold of $90,337,478 · 14 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 11, 2021 · D/A · $64,337,469 sold of $90,337,478 · 14 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 16, 2021 · D/A · $44,837,460 sold of $90,337,478 · 14 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 5, 2021 · D · $42,337,461 sold of $90,337,478 · 13 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $90.3M from 14 investors (90% of the $100M target) as of the latest filing. Christopher is listed as director on 5 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

KD
Biotechnology · group: Kineta

KINETA, INC./DE

Seattle, WA · Jun 2, 2011 → Sep 15, 2015 · 5 filings
  • Sep 15, 2015 · D · $21,999,992 sold of $27,999,992 · 9 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 15, 2015 · D/A · $15,000,000 sold of $15,000,000 · 8 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 7, 2014 · D/A · $5,000,000 sold of $10,000,000 · 7 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 14, 2014 · D · $3,012,271 sold of $10,000,000 · 5 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 2, 2011 · D/A · $70,623,000 sold of $81,760,000 · 7 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $70.6M from 17 investors (100% of the $28M target) as of the latest filing. Christopher is listed as director on 5 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

TS
Biotechnology

Theraclone Sciences, Inc.

Seattle, WA · Mar 17, 2010 → May 7, 2015 · 7 filings
  • May 7, 2015 · D · $3,080,000 sold of $4,408,149 · 12 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 29, 2013 · D/A · $6,000,000 sold of $6,396,000 · 2 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 29, 2013 · D · $6,000,000 sold of $6,396,000 · 2 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 26, 2013 · D · $4,000,000 sold of $8,000,001 · 18 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 23, 2011 · D/A · $11,584,603 sold of $11,584,603 · 13 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 12, 2011 · D · $10,584,603 sold of $10,584,603 · 12 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 17, 2010 · D · $1,500,000 sold of $1,500,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $11.6M from 18 investors (100% of the $4.41M target) as of the latest filing. Christopher is listed as director on 7 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

GP
Biotechnology

GALLEON PHARMACEUTICALS INC

Horsham, PA · Nov 20, 2013
  • Nov 20, 2013 · D · $1,500,000 sold of $1,500,000 · 3 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $10M from 3 investors (100% of the $1.5M target) as of the latest filing. Christopher is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

T
Pharmaceuticals

TREVENA INC

King of Prussia, PA · Jul 16, 2010 → May 17, 2013 · 2 filings
  • May 17, 2013 · D · $59,999,997 sold of $60,000,000 · 9 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 16, 2010 · D · $17,500,000 sold of $41,000,000 · 8 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $60M from 9 investors (100% of the $60M target) as of the latest filing. Christopher is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

SC
Other Technology

SYNOVEX CORP

Boston, MA · Oct 10, 2012
  • Oct 10, 2012 · D · $3,500,004 sold of $7,000,001 · 5 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $3.5M from 5 investors (50% of the $7M target) as of the latest filing. Christopher is listed as executive officer, director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

AC
Pharmaceuticals · group: Healthcare

Apofore Corp

Cambridge, MA · Aug 1, 2011
  • Aug 1, 2011 · D · $500,000 sold of $10,000,000 · 2 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $500K from 2 investors (5% of the $10M target) as of the latest filing. Christopher is listed as executive officer, director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

A
Biotechnology · group: Healthcare

Anexon, Inc.

Cambridge, MA · Oct 19, 2010 → Oct 19, 2010 · 3 filings
  • Oct 19, 2010 · D · $2,000,000 sold of $12,000,001 · 4 investors · min. $41,667 · role: Executive Officer, Director EDGAR ↗
  • Oct 19, 2010 · D · $2,000,000 sold of $2,000,000 · 2 investors · min. $250,000 · role: Executive Officer, Director EDGAR ↗
  • Oct 19, 2010 · D · $3,000,000 sold of $3,000,000 · 2 investors · min. $83,333 · role: Executive Officer, Director EDGAR ↗

Raised $3M from 4 investors (25% of the $12M target) as of the latest filing. Christopher is listed as executive officer, director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

A
Other

AnchorTherapeutics, Inc

Cambridge, MA · May 27, 2009 → Aug 23, 2010 · 2 filings
  • Aug 23, 2010 · D · $5,000,000 sold of $15,000,000 · 4 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 27, 2009 · D/A · $18,999,997 sold of $18,999,997 · 4 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $19M from 4 investors (100% of the $15M target) as of the latest filing. Christopher is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

HV
Pooled Investment Fund · group: Healthcare

HealthCare Ventures IX, L.P.

Cambridge, MA · Apr 27, 2010
  • Apr 27, 2010 · D · $0 sold of $250,000,000 · 0 investors · min. $50,000 · role: Director EDGAR ↗

No sales reported yet as of the latest filing. Christopher is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

People around Christopher 40

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.

HP
Management entity

HealthCare Partners IX, L.P.

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Christopher Mirabelli. Their page shows their other deals.

HM
Management entity

HCV Management IX LLC

Director · 1 shared filing (1 issuer)

Listed on the same filings as Christopher Mirabelli. Their page shows their other deals.

WH
No photo found yet (own website and image search run after this page is viewed)
Person

Wende Hutton

Director · 7 shared filings (1 issuer) · also on 17 other issuers

Wende Hutton is on 18 issuers in total — a repeat sponsor. Their page lists every one.

SG
No photo found yet (own website and image search run after this page is viewed)
Person

Steven Gillis

Executive Officer, Director · 7 shared filings (1 issuer) · also on 29 other issuers

Steven Gillis is on 30 issuers in total — a repeat sponsor. Their page lists every one.

RH
No photo found yet (own website and image search run after this page is viewed)
Person

Russ Hawkinson

Executive Officer · 7 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Christopher Mirabelli. Their page shows their other deals.

AL
No photo found yet (own website and image search run after this page is viewed)
Person

Augustine Lawlor

Director, Executive Officer · 7 shared filings (4 issuers) · also on 12 other issuers

Augustine Lawlor is on 16 issuers in total — a repeat sponsor. Their page lists every one.

DO
No photo found yet (own website and image search run after this page is viewed)
Person

Douglas E. Onsi

Director, Executive Officer · 6 shared filings (4 issuers) · also on 4 other issuers

Douglas E. Onsi is on 8 issuers in total — a repeat sponsor. Their page lists every one.

MS
No photo found yet (own website and image search run after this page is viewed)
Person

Marten Steen

Director · 5 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Christopher Mirabelli. Their page shows their other deals.

SD
No photo found yet (own website and image search run after this page is viewed)
Person

Susan B Dillon

Executive Officer, Director · 5 shared filings (1 issuer)

Listed on the same filings as Christopher Mirabelli. Their page shows their other deals.

KN
No photo found yet (own website and image search run after this page is viewed)
Person

Karyn O'Neil

Executive Officer, Director · 5 shared filings (1 issuer)

Listed on the same filings as Christopher Mirabelli. Their page shows their other deals.

ML
No photo found yet (own website and image search run after this page is viewed)
Person

Mark Laurenzi

Executive Officer · 5 shared filings (1 issuer)

Listed on the same filings as Christopher Mirabelli. Their page shows their other deals.

EA
No photo found yet (own website and image search run after this page is viewed)
Person

Elizabeth Anderson

Director · 5 shared filings (1 issuer)

Listed on the same filings as Christopher Mirabelli. Their page shows their other deals.

KR
No photo found yet (own website and image search run after this page is viewed)
Person

Kevin Raidy

Director · 5 shared filings (1 issuer)

Listed on the same filings as Christopher Mirabelli. Their page shows their other deals.

SG
No photo found yet (own website and image search run after this page is viewed)
Person

Scott Greenberg

Executive Officer · 5 shared filings (1 issuer)

Listed on the same filings as Christopher Mirabelli. Their page shows their other deals.

JK
No photo found yet (own website and image search run after this page is viewed)
Person

JEFFERY KELLY

Director · 5 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Christopher Mirabelli. Their page shows their other deals.

BP
No photo found yet (own website and image search run after this page is viewed)
Person

Bruce Peacock

Director · 5 shared filings (1 issuer) · also on 5 other issuers

Bruce Peacock is on 6 issuers in total — a repeat sponsor. Their page lists every one.

LS
No photo found yet (own website and image search run after this page is viewed)
Person

Lauren Silverman

Director · 4 shared filings (2 issuers) · also on 5 other issuers

Lauren Silverman is on 7 issuers in total — a repeat sponsor. Their page lists every one.

SK
No photo found yet (own website and image search run after this page is viewed)
Person

STEPHEN KNIGHT

Director · 4 shared filings (1 issuer) · also on 8 other issuers

STEPHEN KNIGHT is on 9 issuers in total — a repeat sponsor. Their page lists every one.

CS
No photo found yet (own website and image search run after this page is viewed)
Person

Clifford Stocks

Executive Officer, Director · 4 shared filings (1 issuer) · also on 5 other issuers

Clifford Stocks is on 6 issuers in total — a repeat sponsor. Their page lists every one.

WR
No photo found yet (own website and image search run after this page is viewed)
Person

Wendye Robbins

Director · 4 shared filings (1 issuer)

Listed on the same filings as Christopher Mirabelli. Their page shows their other deals.

KS
No photo found yet (own website and image search run after this page is viewed)
Person

Kristine Swiderek

Executive Officer · 4 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Christopher Mirabelli. Their page shows their other deals.

BD
No photo found yet (own website and image search run after this page is viewed)
Person

BERNARD DAVITIAN

Director · 4 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Christopher Mirabelli. Their page shows their other deals.

JS
No photo found yet (own website and image search run after this page is viewed)
Person

JANET SMART

Executive Officer · 4 shared filings (1 issuer)

Listed on the same filings as Christopher Mirabelli. Their page shows their other deals.

JL
No photo found yet (own website and image search run after this page is viewed)
Person

Jess Lifton

Director · 4 shared filings (1 issuer)

Listed on the same filings as Christopher Mirabelli. Their page shows their other deals.

MC
No photo found yet (own website and image search run after this page is viewed)
Person

MEENU CHHABRA

Executive Officer, Director · 4 shared filings (1 issuer)

Listed on the same filings as Christopher Mirabelli. Their page shows their other deals.

SN
No photo found yet (own website and image search run after this page is viewed)
Person

Steven Van Nurden

Director · 3 shared filings (1 issuer)

Listed on the same filings as Christopher Mirabelli. Their page shows their other deals.

WC
No photo found yet (own website and image search run after this page is viewed)
Person

Witold Cieplak

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Christopher Mirabelli. Their page shows their other deals.

TD
No photo found yet (own website and image search run after this page is viewed)
Person

Thomas Dietz

Director · 3 shared filings (2 issuers)

Listed on the same filings as Christopher Mirabelli. Their page shows their other deals.

SG
No photo found yet (own website and image search run after this page is viewed)
Person

Saan-Chirag Gandhi

Director · 3 shared filings (1 issuer)

Listed on the same filings as Christopher Mirabelli. Their page shows their other deals.

CW
No photo found yet (own website and image search run after this page is viewed)
Person

CHRISTOPHER WALSH

Director · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Christopher Mirabelli. Their page shows their other deals.

WG
No photo found yet (own website and image search run after this page is viewed)
Person

William Greene

Director · 2 shared filings (1 issuer) · also on 10 other issuers

William Greene is on 11 issuers in total — a repeat sponsor. Their page lists every one.

FC
No photo found yet (own website and image search run after this page is viewed)
Person

Farah Champsi

Director · 2 shared filings (1 issuer) · also on 6 other issuers

Farah Champsi is on 7 issuers in total — a repeat sponsor. Their page lists every one.

CW
No photo found yet (own website and image search run after this page is viewed)
Person

CHRISTOPHER T. WALSH

Director · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Christopher Mirabelli. Their page shows their other deals.

HS
No photo found yet (own website and image search run after this page is viewed)
Person

Henry Skinner

Director · 2 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Christopher Mirabelli. Their page shows their other deals.

MG
No photo found yet (own website and image search run after this page is viewed)
Person

Maxine Gowen

Executive Officer, Director · 2 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Christopher Mirabelli. Their page shows their other deals.

RG
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Garland

Director · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Christopher Mirabelli. Their page shows their other deals.

TM
No photo found yet (own website and image search run after this page is viewed)
Person

Terence McGuire

Director · 2 shared filings (1 issuer)

Listed on the same filings as Christopher Mirabelli. Their page shows their other deals.

MB
No photo found yet (own website and image search run after this page is viewed)
Person

M. James Barrett

Director · 2 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Christopher Mirabelli. Their page shows their other deals.

MC
No photo found yet (own website and image search run after this page is viewed)
Person

MICHAEL CASEY

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Christopher Mirabelli. Their page shows their other deals.

MH
No photo found yet (own website and image search run after this page is viewed)
Person

MARKUS HAEBERLEIN

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Christopher Mirabelli. Their page shows their other deals.

The team behind the deals

H
Sponsor group

Healthcare

6 issuers · 11 filings · $81.2M reported sold · 2010–2023

One team, 6 deal companies. Christopher Mirabelli is listed on 4 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Christopher Mirabelli.

K
Sponsor group

Kineta

8 issuers · 58 filings · $19M reported sold · 2010–2023

One team, 8 deal companies. Christopher Mirabelli is listed on 1 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Christopher Mirabelli.

Same business address

24 other issuers file from the same address

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Adviser registration (Form ADV)

None of the 11 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Christopher Mirabelli by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 11 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Christopher Mirabelli is listed on: none on file. No website or social profile named in KINETA, INC./DE's SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #115,093 of 374,652 in line (14 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Seattle, WA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗Massachusetts MassCourts ↗New Jersey state courts — find the court ↗Pennsylvania UJS portal case search ↗Washington Courts case search (dw.courts.wa.gov) ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

Massachusetts Secretary of State business search ↗New Jersey Secretary of State business search ↗Pennsylvania Secretary of State business search ↗Washington Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Christopher Mirabelli appears on a new Form D, or when a court case or SEC action is matched to them. See plans →